Compound Library

SARM / Classic SARM

LGD-2226

Early-generation selective androgen receptor modulator. Highly bioavailable oral. Bone and muscle anabolic. Less studied than LGD-4033. Phase 1 trials completed.

Build protocol outline Open dose calculator TNHL ebooks
Educational reference only. This page does not diagnose, prescribe, or replace care from a licensed professional. Laws, availability, and clinical appropriateness vary by location.
Reference dose5–10 mg/day. Max 8 weeks.
Half-life24 hours
Risk flagmoderate
Regulatory noteResearch-only flag

Side effects and watch-outs

  • HPTA suppression
  • Hair loss
  • Liver enzyme elevation
  • HDL suppression
  • ⚠️ Unapproved research compound — limited human data